MEDRAD received FDA clearance for use of its Continuum MR infusion system in MR environments up to and including 3.0 T. The new FDA clearance enables clinicians working in the latest 3.0 T environments to infuse medications, sedatives and other drugs, while benefiting from Continuum’s dose enhancements. The system passed tests for homogeneity, artifact and static magnetic field.